Upgrade

Finvezto Toolkit

Cohance Lifesciences' Pashamylaram plant in Hyderabad received a USFDA Voluntary Action Indicated classification.

Legal · Finvezto · 7 Nov 2026 · Cohance Lifesciences (COHANCE)

What happened

Cohance Lifesciences' Pashamylaram plant in Hyderabad received a USFDA Voluntary Action Indicated classification. Source: Stock note

Why it matters

Anand Ganapathy K: It closes the July-August inspection that produced five Form 483 observations, and no further FDA action is needed. It follows the Suryapet closure order a day earlier. Source: Stock note

Links

Company page

Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630.